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Summary
Screening and carotid endarterectomy have been 
advocated for asymptomatic carotid stenosis. However, the 
risk of stroke w ithout treatment has not been adequately 
defined.
We investigated the risk of stroke in the distribution of 
the asymptomatic carotid artery in 2295 patients 
randomised in the European Carotid Surgery Trial. During a 
mean follow-up of 4-5 years, there were 69 carotid territory 
strokes, nine of which were fatal, giving three year Kaplan- 
Meier risks of stroke and fatal stroke of 2-1% (95% Cl, 
1-5-2-8) and 0-3% (95% Cl, 0*06-0-56) respectively. The 
stroke risk in the 127 patients with severe (70-99%) 
carotid stenosis was 5-7% (95% Cl, 1-5-9-8).
Given these low stroke risks, the potential benefit of 
endarterectomy for asymptomatic carotid stenosis is 
small. Population screening is not justified and 
endarterectomy for asymptomatic carotid stenosis should 
only be performed in the context of weil organised 
randomised controlled trials.
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introduction
Patients with a recent carotid distribution transient 
ischaemic attack or non-disabling ischaemic stroke, and a 
severe stenosis of the relevant carotid artery, can benefit 
from carotid endarterectomy/*2 Although endarterectomy 
for asymptomatic carotid stenosis has been advocated,3-7 
there is no clear evidence of benefit. Between 5 and 10% 
of the general population over 65 years of age8’9 and 
between 20 and 30% of patients attending hospital 
because of ischaemic heart disease or peripheral vascular 
disease10,11 have more than 50% stenosis of one carotid 
artery, A policy of surgery for asymptomatic carotid 
stenosis would therefore have major public health 
implications.
There is a mortality risk of about 1 % and a stroke risk 
of between 5 and 10% in patients who have had 
endarterectomy for symptomatic stenosis, 1*2 and so the 
risk of stroke in the distribution of an asymptomatic 
stenosis needs to be substantial to justify surgery. As yet 
this risk has not been adequately determined and
»reported annual stroke risks vary from less than 1% 12 to 
18%.13 Much of the existing data were gathered 
retrospectively, and none of the prospective studies were
jlarge enough to give stroke risks with narrow confidence 
intervals for different degrees of carotid stenosis. 12,I4~19 
Moreover, the most important outcome—disability due to 
stroke—has not been studied.
The European Carotid Surgery Trial (ECST) was set 
up to examine the efficacy of carotid endarterectomy in 
patients who had symptomatic carotid stenosis. 3026 
patients were randomised; most had unilateral 
cerebrovascular symptoms but had had bilateral carotid 
angiography. These patients had an angiographically 
defined asymptomatic carotid artery (ie, one that was not 
associated with any symptoms), and were followed up 
regularly by a neurologist, with all strokes and related 
disability recorded. Our results enabled us to study the 
risk of stroke in patients with asymptomatic carotid 
arteries who received standard medical therapy.
4
Patients and methods
Patients were randomised if they had had a carotid-distribution 
transient ischaemic attack, a minor ischaemic stroke, a non­
disabling major ischaemic stroke, or a retinal infarction within 
the previous 6 monthsj and if the neurologist and surgeon were 
uncertain whether to recommend carotid endarterectomy after 
the patient had had a carotid angiogram. Patients came from over 
100 centres in 14 European countries and were randomised to 
“immediate surgery” (60%) or to “avoid immediate surgery” 
(40%). Clinicians ensured that both groups had “best medical 
treatment” which usually included aspirin or another anti-platelet 
drug, treatment of hypertension, and advice to stop smoking. 
When patients were randomised certain baseline clinical data




Characteristics Degree of symptomless stenosis {%)
0-29 30-69 70-99 Occlusion
Number of patients 1270 843 127 55
Mean age (yr) 61-5 62-9 64-4 64-2
Male {%) 71*2 69-7 70-9 72-7
Previous angina and/or 19-2 27-0 334 27-3*
myocardial infarction (%)
Peripheral vascular disease (%) 13-2 20-0 23-6 38’2 f
Diabetic {%) 10'6 10-5 14-2 10-9
Mean systolic BP (mm Hg) 149 152 157 150t
Mean diastolic BP (mm Hg) 86 87 87 86
Mean cholesterol (mmol/l) 6-4 6-5 6-5 6-3
Current cigarette smokers (%) 53 52 50 56
Mean obesity index (kg/m2) 25-1 25-4 25-8 25*3
*Xt for linear trend=2l*4, p<0-001. fx s for [¡near trend=38*2, p<0-001, ¡{¡Regression 
' analysis for trend, p=0-014.
Table 1; Baseline characteristics of 2295 patients studied
were recorded (table 1) and sent to the main trial centre along 
with the pre-randomisation carotid angiogram, a pre- 
randomisation computed tomographic (CT) brain scan (if 
abnormal), an electrocardiogram, and details of the nature and 
outcome of any carotid surgery. The degree of stenosis in both 
internal carotid arteries was measured by one observer on the 
angiogram by the ECST method as previously described.1120
Follow-up was done at 4 and 12 months after randomisation 
(then annually) by the neurologist. At each follow-up visit the 
neurologist recorded any strokes or myocardial infarctions that 
had occurred since the previous visit, any further carotid surgery, 
and blood pressure and current medications. For all deaths, non- 
fatal strokes and myocardial infarctions occurring after 
randomisation* clinical details, including CT scan and necropsy 
reports were sent to the main trial centre for classification by a 
neurologist and then by a blinded clinical audit committee. For 
each stroke during follow-up, the local neurologist recorded the 
actual or expected disability on the Rankin scale21 6 months 
afterwards.
Our study was confined to the 2695 patients randomised in the 
ECST prior to January 1992, so that baseline data were complete 
and all patients had at least one year of follow-up. We excluded 
205 patients because of a history of transient ischaemic attacks 
or strokes in the territory of both carotid arteries. We also 
excluded a further 15 patients, randomised to surgery, who had 
bilateral endarterectomy shortly after randomisation, and 180 
patients with an absent or inadequate angiographic view of the 
asymptomatic carotid artery. Thus 2295 patients were eligible for 
the study. At least 1 year of follow-up data were available in 2252 
patients (98*1%). The main outcome was first ’ stroke, 
haemorrhage, or infarct, in the distribution of asymptomatic 
carotid artery, which was fatal or lasted more than 7 days. For
Degree of symptomless stenosis (%) Total
0-29 30-69 70-99 Occlusion
Patients 1270 843 127 55 2295
Strokes 28 26 13 2 69
Kaplan-Meler 3-year risk 1-8% 24% 5-7% 3-7% 24%
(95% Cl) (11-2-6) (14-3-2) {1* 5-9-8) (0-8*9) (1-5-2-8)
CT scan appearance
Infarction 17 15 8 0 40
Haemorrhage 2 1 0 0 3
No CT scan available 9 10 5 2 26
Strokes after 
endarterectomy
Symptomatic side surgery 3 0 2 0 5
Asymptomatic side surgery 1 2 4 0 7
Status after 6 months 
post-stroke
Rankin 0-2 16 15 4 1 36
Rankin >2 5 4 4 1 14
Not known 5 3 2 0 10
Dead 2 4 3 0 9
Table 2: Details of all strokes lasting more than 7 days in 
distribution of asymptomatic carotid artery
Years from randomisation
Figure 1: Actuarial analysis of survival free from stroke lasting 
longer than 7 days In the distribution of an asymptomatic 
artery
comparison the risk of stroke, defined in the same way, in the 
distribution of the symptomatic carotid artery was analysed in 
the same 2295 patients.
Statistical analysis
We used life-table methods and logrank tests for formal analyses 
of time from randomisation to first stroke, censoring for non­
stroke death.
Results
Mean duration of follow-up was 4*5 years (range 1-11-4). 
The prevalence of ischaemic heart disease and peripheral 
vascular disease and mean systolic blood pressure 
increased with the degree of asymptomatic stenosis, but 
there were no other significant differences between 
patients with. mild (0-29%), moderate (30-69%) or 
severe (70-99%) asymptomatic stenosis (table 1). 480 
patients had a stenosis of less than 10%.
Five strokes in the distribution of the asymptomatic 
artery occurred within 30 days of carotid enrterectomy 
performed on the symptomatic artery. Of the 37 patients 
who had endarterectomy on the asymptomatic artery at 
some stage during follow-up, seven had a stroke in the 
vesssels supplied by operated artery within 30 days of 
surgery (table 2). The reason given for endarterectomy on 
the asymptomatic side was development of a transient 
ischaemic attack or stroke in 19 cases (stenosis: 4 mild, 7 
moderate; 8 severe), but in 11 cases endarterectomy was 
done specifically for asymptomatic stenosis (stenosis: 2 
moderate; 9 severe), and in 7 cases (stenosis: 2 moderate;
5 severe) the reason for surgery was unknown. All surgical 
strokes were included in the analysis of stroke risk. 
Overall, 69 patients had a first stroke lasting longer than 7 
days in distribution of the asymptomatic carotid artery 
during follow-up. This gave an overall Kaplan-Meier 
estimate of stroke risk at 3 years of 2*1% (95% Cl: 
1-5-2-8). The stroke risk was almost identical in patients 
with mild and moderate stenosis (table 2 and figure l)j 
but the 3 year risk increased to 9-8% (95% Cl: 0*6- 21) in 
patients with 80-89% stenosis, and to 14*4% (95% Cl: 
5-38) in patients with 90-99% stenosis (figure 2). 
However, neither these risks3 nor the 5-7% risk in patients 
with 70-99% stenosis as a whole, were statistically 
significantly greater than the stroke risk in the rest of the 
group. The 30-day case fatality of stroke was 13%^  giving 
a Kaplan-Meier three-year risk of fatal stroke of 0*3%
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Figure 2: Kaplan-Meier 3-year estimates (95% Cl) of risk of 
stroke tasting longer than 7 days In distribution of 
asymptomatic artery
Number above error bar indicates number of patients in each stenosis 
group.
(0-06-0-56). A Rankin disability score was available in 50 
(83%) of the 60 non-fatal strokes (table 2). Of these, 14 
(28%) were disabling (Rankin >2) at 6 months. If the 
strokes in which degree of disability was unknown are 
regarded as disabling the Kaplan-Meier three-year risk of 
a disabling or fatal stroke was 1-0% (0-3-1-8). The risk of 
stroke on the asymptomatic side did not differ 
significantly with treatment allocated for the symptomatic 
stenosis (surgery: 40/1390 [2-9%] compared with no 
surgery: 29/905 [3-2%]).
Figure 3 shows the Kaplan-Meier curves derived from 
our analysis of follow-up. The three-year risk of carotid 
distribution stroke ipsilateral to a severe symptom-free 
stenosis (5*7%, CI: 1 *5-9*8) was significantly less than the 
same risk ipsilateral to a severe symptomatic stenosis with 
medical treatment (17-1%, 13*3-20*1), and was not 
significantly greater than the risk ipsilateral to a severe 
symptomatic stenosis after successful endarterectomy
(3-1%, 1 *4-4*4),
100 (2) Endarterectomy for severe symptomatic stenosis (excluding surgical stroke or death)
9 0 -
1~“W
(1) Severe asymptomatic 
stenosis













Figure 3: Actuarial analysis of survival free from stroke in the 
distribution of a severe (70-99%) carotid stenosis
(1) patients with asymptomatic stenosis including all carotid territory 
strokes ipsilateral to the asymptomatic stenosis; (2) patients with 
symptomatic stenosis randomised to carotid endarterectomy, excluding 
all surgery-related strokes and deaths, ie, the background ipsilateral 
stroke risk after successful surgery; (3) patients with symptomatic 
stenosis randomised to medical treatment, including all carotid territory 
ischaemic strokes ipsilateral to the symptomatic stenosis.
Discussion
In patients with symptomatic carotid stenosis, the degree 
of stenosis is the most important predictor of stroke risk 
in the territory of the symptomatic artery.1*2 Because of 
the increasing interest in carotid endarterectomy for 
patients with asymptomatic stenosis, the relation between 
the degree of stenosis and stroke risk with medical 
treatment should be determined accurately. Our study is 
the largest study of risk of stroke in patients with an 
asymptomatic carotid artery. All stenoses were imaged 
with angiography, which allows the degree of stenosis to 
be measured accurately and reproducibly.22 Ultrasound 
imaging, used in previous studies,12*14'10 is less 
reproducible.23 The overall 2-1% 3-year risk of stroke in 
the distribution of asymptomatic stenoses is low, but is 
unlikely to be an underestimate. Follow-up was done 
regularly by experienced neurologists, and was complete 
in over 98% of cases. All strokes were counted, including 
those caused by surgery on the symptomatic or 
asymptomatic artery. The patients studied had all had 
symptoms arising from the contralateral carotid stenosis, 
had a high frequency of diabetes, ischaemic heart disease, 
and peripheral vascular disease, and over half were 
cigarette smokers. However, endarterectomy performed 
on the asymptomatic artery may have prevented a small 
number of strokes in a few patients. We did not include 
patients whose symptoms of stroke lasted less than 7 days.
The low risk of stroke in our study concurs with 
ultrasound-based studies of risk of stroke in the 
distribution of asymptomatic carotid arteries. Chambers 
and Norris followed up patients with asymptomatic 
stenosis for a mean of 2 years,17 and reported 6 strokes in 
113 patients with 75-100% stenosis. Hennerici et al13 
followed up 235 patients with more than 50% 
asymptomatic stenosis for a mean of 32 months and 
reported 7 strokes. Bogousslavsky et al14 followed-up 38 
patients with 90-99% asymptomatic stenosis for a mean 
of 4 years and reported 3 ischaemic strokes.
Each year 5-20% of patients with a previously 
asymptomatic carotid stenosis are said to have 
neurological events or cerebral ischaemic events.15*1’124,25 A 
clinical trial of carotid endarterectomy for asymptomatic 
stenosis reported a significant reduction in cerebral 
ischaemic events in the treated group, although there was 
no significant effect on the risk of stroke or death.26 In all 
these studies, most events were transient ischaemic 
attacks. Although from a pathophysiological point of view, 
it can be argued that the distinction between transient 
ischaemic attacks and stroke is arbitrary, an outcome 
which gives equal weight to transient events that do not 
cause lasting disability and major strokes that cause death 
or lifelong dependency, is too broad to have any real 
clinical meaning. Furthermore, it is misleading to 
compare the risk of such events with the quoted risks of 
carotid endarterectomy, which only include stroke or 
death.1*2*4 In order that patients should not be 
inadvertently misinformed about the balance of risks and 
benefits of surgery for asymptomatic stenosis we did not 
analyse the risk of transient ischaemic attacks during 
follow-up.
The burden of disability that results from stroke in the 
distribution of asymptomatic carotid stenosis has not been 
measured previously. Although stroke is less 
heterogeneous than the term cerebral ischaemic events, 
there is still variation in the severity of stroke, ranging 
from minor sensory disturbance to devastating permanent
Voi 345 • January 28, 1995 211
THE LANCET
hemiparesis with aphasia or neglect. Therefore we should 
categorise strokes as non-disablings disabling, or fatal. 
The case fatality of stroke in this study was 13%. In over 
70% of the non-fatal strokes for which a Rankin score was 
available, there was no significant disability 6 months 
later.
The risks of stroke in patients with 80-90% and 
90-99% stenosis were based on small numbers of patients 
with very few outcome events, and the confidence 
intervals were therefore extremely wide. The overall risk 
in patients with 70-99% stenosis was lower, but was 
based on a larger number of patients and therefore has 
greater validity. What might be gained from 
endarterectomy performed for severe asymptomatic 
stenosis? The background risk of carotid distribution 
stroke after successful endarterectomy, which are 
probably largely caused by lacunar and cardio-embolic 
strokes, should be accounted for. The risk of stroke in the 
distribution of the asymptomatic artery may be somewhat 
greater than the background risk of ipsilateral carotid 
distribution stroke after successful endarterectomy for 
«symptomatic stenosis (figure 3). However, this difference 
in risk was not statistically significant.
Surgical mortality and morbidity will have to be 
considerably lower than in trials of endarterectomy in 
symptomatic patients1’2 if surgery for asymptomatic 
stenosis is to be beneficial. Indeed, even the stringent 3% 
limit on risk of stroke and death recommended by the 
American Heart Association for surgeons operating on 
asymptomatic stenoses3 would probably nullify any 
benefit. Even with complication-free surgery, the cost 
effectiveness of the procedure must be in doubt: about 
five strokes prevented over five years following successful 
endarterectomy in 127 patients with severe asymptomatic 
stenosis (figure 3).
The risks of fatal, disabling, and non-disabling stroke in 
the distribution of the asymptomatic carotid artery in 
patients receiving medical treatment are low. Screening 
with a view to prophylactic endarterectomy would be 
undermined by the prevention paradox;27 most strokes (54 
out of 69 patients) occurred in low-risk patients with mild 
or moderate stenosis, with only a small proportion in 
patients with severe stenosis (table 2). Prognostic 
modelling may identify patients at high risk of stroke, but 
in the meantime endarterectomy cannot be justified for 
asymptomatic carotid stenosis without a randomised 
controlled trial. Since the cost-effectiveness and public 
health impact of the procedure are likely to be marginal, 
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